[ALNY] YoY Annual Result on 31-Dec-2012 [#FY]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
19-Feb-2013
Financial Year
2012
Quarter
31-Dec-2012 [#FY]
Profit Trend
YoY- -83.90%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Annual Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 41,097 50,561 47,167 66,725 82,757 100,041 100,533 -13.84%
PBT -290,073 -400,604 -91,920 -116,586 -57,649 -43,001 -47,008 35.41%
Tax -24,909 -40,209 -2,695 -10,572 -5,799 514 582 -
NP -290,073 -360,395 -89,225 -106,014 -57,649 -43,515 -47,590 35.13%
Tax Rate - - - - - - - -
Total Cost 331,170 410,956 136,392 172,739 140,406 143,556 148,123 14.34%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin -705.83 -712.79 -189.17 -158.88 -69.66 -43.50 -47.34 56.85%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS -3.45 -4.85 -1.45 -2.11 -1.36 -1.04 -1.14 20.25%
EPS Diluted -3.45 -4.85 -1.45 -2.11 -1.36 -1.04 -1.14 20.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.